LGM Pharma Boosts US Manufacturing with Additional $9 Million Investment
LGM Pharma invests an additional $9 million to expand US manufacturing, bringing total investment to $15 million across its Texas and Colorado facilities.
Contract Development And Manufacturing Organizations (CDMO)
Ice Pharma Expands Beyond APIs to Create New Bile Acid Markets
Ice Pharma recently announced a strategic expansion beyond its core API business, positioning the company to compete in higher-value finished dosage, nutraceutical, and specialty excipient markets.
CordenPharma Colorado Partners with BioMed Realty on Peptide Development Lab Expansion
Full-building, 15-year lease for 64,000 square feet enables CDMO CordenPharma Colorado to power next-generation peptide development in Boulder, Colorado.
Axplora Invests $60 Million in HPAPI Expansion at Farmabios Site in Italy
$60 million investment to expand highly potent API (HPAPI) development and manufacturing at Axplora’s Farmabios site in Gropello Cairoli, Italy.
Sandoz Creates New Global Biosimilar Unit
Sandoz has announced the creation of a new biosimilar development, manufacturing and supply unit.
Symbiosis Appoints Joanne Anderson as Chief Commercial Officer
Symbiosis Pharmaceutical Services has appointed experienced commercial leader Joanne Anderson as Chief Commercial Officer to drive global growth following recent capacity investments and expansion plans.
Lonza Divests Capsules & Health Ingredients Business for $3 Billion
Lonza signs agreement to divest its Capsules & Health Ingredients (CHI) business to Lone Star Funds, for an enterprise value of $3 billion (CHF 2.3 billion).
Forma Life Sciences Launches US Based CDMO
Forma Life Sciences launches as US-based contract development and manufacturing organization (CDMO) for oral solid dosage development and commercial manufacturing in Irvine, California.
Leading CROs and CDMOs Turn to Mass Photometry for Rapid Protein, mRNA and Viral Vector Analytics
As CROs and CDMOs expand their role in biopharma development and manufacturing, fast, accurate bioanalytic technologies remain critical to biotherapeutic affordability.
Axplora Expands Le Mans Lyophilization Operations, Appoints New Head of Site
Axplora announced a multi-million-euro investment to expand lyophilization capabilities at its Le Mans site and appointed François Houbart as Head of Site.
Fujifilm Biotechnologies Unveils Biomanufacturing & Process Development UK Expansion
Fujifilm Biotechnologies expanded manufacturing and process development presence in the North East of England to support vital biomanufacturing of innovative medicines and vaccines in the United Kingdom.
Rentschler Biopharma Appoints Veit Bergendahl as COO
Veit Bergendahl will assume operational responsibility for process development, clinical and commercial cGMP manufacturing, engineering and technology as well as automation in production from April 1, 2026.
WuXi Biologics Boosts Complex Biologics Pipeline
WuXi Biologics partners with Sinorda on bispecific antibodies for autoimmune diseases and HanchorBio on fusion proteins for oncology and immunology.
Siegfried to Acquire Small Molecules Drug Substance Capacity in the US
Siegfried signed binding agreements to acquire three drug substance sites in the US and Australia.
Agno Pharma Acquires US cGMP API Manufacturing Site
Agno Pharma acquired Actylis's Eugene, Oregon CDMO facility, formerly Cascade Chemistry, for small-molecule API development and manufacturing, thereby expanding its US footprint.
Adapting, Partnering, and Innovating: Insights from CPhI Frankfurt
How CDMOs are navigating uncertainty, forging partnerships, and embracing flexibility.
Resilient Industry Adapts to Challenges
SOCMA’s 2026 Contract Manufacturing Outlook shows a resilient, innovative specialty chemical sector, with SMBs driving agility amid tariffs, regulatory complexity, and global uncertainty.
WuXi AppTec Sells China Clinical Research Business to Sharpen Focus
WuXi AppTec has agreed to sell its China-based clinical research services business, including WuXi Clinical and WuXi MedKey, to Hillhouse Investment Management.
Curia Invests $4 Million to Enhance Sterile API Manufacturing
Curia has completed a $4 million upgrade to its sterile API manufacturing suites in Valladolid, Spain, to enhance product quality, safety, and regulatory compliance.
Hovione Completes $100 Million Investment to Expand Operations at US Manufacturing Site
Hovione has completed a $100 million investment to double spray-drying capacity and expand its East Windsor, New Jersey site, positioning the facility to meet growing US demand.
SK Pharmteco Invests $6.1 Million in Peptide Manufacturing at California Facility
SK Pharmteco has announced a $6.1 million investment to expand its Rancho Cordova, California, facility with new lab and kilo-scale capabilities for solid-phase peptide synthesis and purification.
Orion and Abzena Announce Exclusive Antibody Commercial License
Abzena, an end-to-end integrated CDMO for complex biologics and bioconjugates, announced that Orion has obtained an exclusive focused commercial license to one of Abzena’s mAbs..
ESIM Chemicals Files for Bankruptcy
ESIM Chemicals filed for bankruptcy proceedings at the Linz Regional Court in mid-October. The Austrian specialty chemicals company is heavily indebted.
SOCMA Report Finds Specialty Chemical Manufacturers Strong, Adaptive, and Positioned for Growth
Three-year outlook highlights investment in automation, cybersecurity, and regulated manufacturing as key drivers of long-term competitiveness.
Aenova Expands Fill & Finish Capacities at its Latina site
Aenova will install an additional filling and manufacturing line at the Latina, Italy, site. This expansion is an important step to meet the increasing global demand for the production of biologics.
Fujifilm Biotechnologies Opens its Commercial-Scale Cell Culture US Manufacturing Site
Fujifilm Biotechnologies has opened one of North America's largest commercial-scale cell culture biomanufacturing sites in Holly Springs, North Carolina, US.
Symeres Appoints Gabriella Gentile as Chief Operating Officer
Symeres has appointed Gabriella Gentile as Chief Operating Officer to lead global operations and drive transatlantic growth, leveraging her extensive experience in the pharmaceutical and biotech sectors.
Siegfried Opens cGMP Viral Vectors Manufacturing Facility
Dinamiqs, a Siegfried company specialized in viral vector design and manufacturing, inaugurated its new cGMP manufacturing facility.
Symeres Acquires DGr Pharma
CRDMO Symeres has acquired DGr Pharma, expanding its capabilities with DGr Pharma’s regulatory and consultancy expertise to provide more comprehensive drug development services.
Bionova Scientific Opens New pDNA Facility in Texas
Bionova Scientific has opened a 10,000 square-foot state-of-the-art plasmid DNA (pDNA) development and production facility in The Woodlands, Texas.
Sanner Appoints Stefan Verheyden CEO
Heino Lennartz will take over the role on an interim basis until Verheyden takes office in fall 2025.
Ofichem Acquires Meribel Pharma Solutions’ Uppsala Site
Ofichem, a European CDMO specialising in high-quality active pharmaceutical ingredients (APIs) and integrated drug development and manufacturing services, has acquired Meribel Pharma Solutions’ site in Uppsala, Sweden.
Abzena Appoints Geoffrey M. Glass as Chief Executive Officer
Abzena, an end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, recently announced that Geoffrey M. Glass has been appointed Chief Executive Officer, effective immediately.
Sanner Opens its First US Production Facility in North Carolina
Sanner, a provider of high-quality healthcare packaging and drug delivery solutions, officially opened its first US-based production facility in Greensboro, North Carolina.
Marianne Späne to Leave Siegfried Management
The pharmaceutical service provider Siegfried has announced changes to its management team. Marianne Späne, who has been with the Swiss CDMO since 2004 and has held the position of Chief Business Officer since the beginning of 2020, is moving to the Board of Directors of the subsidiary Dinamiqs.
Bio Evaluation
Alcami Corporation
Serán Bioscience, LLC
Suanfarma
Asahi Kasei Europe
IDT Biologika GmbH
LGM Pharma
Cerbios-Pharma SA
Ice Pharma
DSM Pharmaceutical Products
GLSyntech LLC
Bachem
Forma Life Sciences
Ferak Berlin GmbH
Upperton Pharma Solutions
Abzena
Mabion
Agno Pharma
Alira Health S.r.l.
Navin Molecular
Mack Brooks Exhibition Ltd – Part of RX
Rentschler Biopharma SE
Syngene International Ltd.
Ofichem Group
Thomson Reuters
PP Consulting
Sandoz AG
Frost & Sullivan
Fraser Dove International
Symbiosis Pharmaceutical Services
WuXi AppTec
SchüllerConsulting
Microinnova Engineering GmbH
ICIG
AmbioPharm, Inc.
ESIM Chemicals GmbH
Axplora
Kurma Partners
Haltermann Ltd.
Arxada AG
Olon S.p.A.
Camelot Management Consultants AG
WeylChem International GmbH
Siegfried
Society of Chemical Manufacturers & Affiliates (SOCMA)
Refeyn Ltd.
GBI Research
Codexis
OneSource Specialty Pharma Limited
FDA Smart